Logo image of CTEK.CA

CLEANTEK INDUSTRIES INC (CTEK.CA) Stock Fundamental Analysis

TSX-V:CTEK - TSX Venture Exchange - CA75101V1013 - Common Stock - Currency: CAD

0.355  -0.05 (-11.25%)

Fundamental Rating

2

CTEK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 27 industry peers in the Energy Equipment & Services industry. There are concerns on the financial health of CTEK while its profitability can be described as average. CTEK is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CTEK was profitable.
In the past year CTEK had a positive cash flow from operations.
CTEK had negative earnings in 4 of the past 5 years.
In multiple years CTEK reported negative operating cash flow during the last 5 years.
CTEK.CA Yearly Net Income VS EBIT VS OCF VS FCFCTEK.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M -6M -8M

1.2 Ratios

CTEK's Return On Assets of 7.84% is fine compared to the rest of the industry. CTEK outperforms 70.37% of its industry peers.
CTEK has a Return On Equity of 63.59%. This is amongst the best in the industry. CTEK outperforms 92.59% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.77%, CTEK is in the better half of the industry, outperforming 62.96% of the companies in the same industry.
Industry RankSector Rank
ROA 7.84%
ROE 63.59%
ROIC 7.77%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CTEK.CA Yearly ROA, ROE, ROICCTEK.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

The Profit Margin of CTEK (10.07%) is better than 81.48% of its industry peers.
With a Operating Margin value of 9.87%, CTEK perfoms like the industry average, outperforming 59.26% of the companies in the same industry.
CTEK has a Gross Margin of 60.85%. This is amongst the best in the industry. CTEK outperforms 96.30% of its industry peers.
In the last couple of years the Gross Margin of CTEK has grown nicely.
Industry RankSector Rank
OM 9.87%
PM (TTM) 10.07%
GM 60.85%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.66%
GM growth 5Y10.99%
CTEK.CA Yearly Profit, Operating, Gross MarginsCTEK.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CTEK is destroying value.
Compared to 1 year ago, CTEK has more shares outstanding
CTEK has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CTEK has been reduced compared to a year ago.
CTEK.CA Yearly Shares OutstandingCTEK.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M 20M 25M
CTEK.CA Yearly Total Debt VS Total AssetsCTEK.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -5.02, we must say that CTEK is in the distress zone and has some risk of bankruptcy.
CTEK has a Altman-Z score of -5.02. This is amonst the worse of the industry: CTEK underperforms 88.89% of its industry peers.
The Debt to FCF ratio of CTEK is 13.29, which is on the high side as it means it would take CTEK, 13.29 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CTEK (13.29) is worse than 62.96% of its industry peers.
CTEK has a Debt/Equity ratio of 4.78. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CTEK (4.78) is worse than 88.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.78
Debt/FCF 13.29
Altman-Z -5.02
ROIC/WACC0.93
WACC8.31%
CTEK.CA Yearly LT Debt VS Equity VS FCFCTEK.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M 8M

2.3 Liquidity

A Current Ratio of 0.82 indicates that CTEK may have some problems paying its short term obligations.
CTEK has a worse Current ratio (0.82) than 88.89% of its industry peers.
CTEK has a Quick Ratio of 0.82. This is a bad value and indicates that CTEK is not financially healthy enough and could expect problems in meeting its short term obligations.
CTEK has a worse Quick ratio (0.79) than 74.07% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.79
CTEK.CA Yearly Current Assets VS Current LiabilitesCTEK.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 162.22% over the past year.
Looking at the last year, CTEK shows a very negative growth in Revenue. The Revenue has decreased by -15.74% in the last year.
The Revenue has been growing by 60.69% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)162.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29%
Revenue 1Y (TTM)-15.74%
Revenue growth 3Y10.15%
Revenue growth 5Y60.69%
Sales Q2Q%0.95%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CTEK.CA Yearly Revenue VS EstimatesCTEK.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CTEK.CA Yearly EPS VS EstimatesCTEK.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 0 -0.05 -0.1 -0.15

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.83, the valuation of CTEK can be described as reasonable.
CTEK's Price/Earnings ratio is in line with the industry average.
CTEK is valuated cheaply when we compare the Price/Earnings ratio to 26.48, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.83
Fwd PE N/A
CTEK.CA Price Earnings VS Forward Price EarningsCTEK.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

CTEK's Enterprise Value to EBITDA is on the same level as the industry average.
CTEK's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 12.98
EV/EBITDA 5.67
CTEK.CA Per share dataCTEK.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CTEK!.
Industry RankSector Rank
Dividend Yield N/A

CLEANTEK INDUSTRIES INC

TSX-V:CTEK (8/7/2025, 7:00:00 PM)

0.355

-0.05 (-11.25%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)04-25 2025-04-25
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners6.7%
Ins Owner ChangeN/A
Market Cap10.41M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 11.83
Fwd PE N/A
P/S 0.88
P/FCF 12.98
P/OCF 5
P/B 5.56
P/tB 6.47
EV/EBITDA 5.67
EPS(TTM)0.03
EY8.45%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.03
FCFY7.71%
OCF(TTM)0.07
OCFY20%
SpS0.4
BVpS0.06
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.84%
ROE 63.59%
ROCE 12.42%
ROIC 7.77%
ROICexc 8.27%
ROICexgc 8.49%
OM 9.87%
PM (TTM) 10.07%
GM 60.85%
FCFM 6.78%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.66%
GM growth 5Y10.99%
F-Score7
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 4.78
Debt/FCF 13.29
Debt/EBITDA 2.67
Cap/Depr 58.69%
Cap/Sales 10.83%
Interest Coverage 1.41
Cash Conversion 62.19%
Profit Quality 67.34%
Current Ratio 0.82
Quick Ratio 0.79
Altman-Z -5.02
F-Score7
WACC8.31%
ROIC/WACC0.93
Cap/Depr(3y)57.43%
Cap/Depr(5y)38.88%
Cap/Sales(3y)11.95%
Cap/Sales(5y)8.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)162.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.74%
Revenue growth 3Y10.15%
Revenue growth 5Y60.69%
Sales Q2Q%0.95%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y411.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-34.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.78%
OCF growth 3YN/A
OCF growth 5YN/A